TRIA Program Reauthorization Act of 2026

What happened: HR 7128, the TRIA Program Reauthorization Act of 2026, extends the federal Terrorism Risk Insurance Program through 2034 (from current 2027 sunset). It also increases the loss certification threshold from $5 million to $25 million and mandates Treasury public notification within 30 days of beginning a certification determination. The bill was introduced January 16, 2026, passed the House Financial Services Committee on March 19 by a 51-2 vote, and was placed on the Union Calendar (Calendar No. 482) same day. It is awaiting a floor vote in the House. The money trail: This is an authorization bill — it extends a program, not a direct spending appropriation. The TRIA program itself is a federal backstop mechanism where the government absorbs a portion of certified terrorism losses above insurer deductibles, with mandatory industry-wide recoupment provisions. No new direct funding is authorized or appropriated in this bill. The financial impact is structural: by extending the backstop, the bill reduces the capital insurers must hold against terrorism tail risk, lowering the cost of underwriting terrorism coverage and supporting premium stability in commercial P&C lines. Structural winners: The four largest US commercial P&C insurers — AIG (American International Group), CB (Chubb), ALL (Allstate), and TRV (Travelers) — are direct beneficiaries. These companies underwrite significant commercial terrorism risk and rely on TRIA to offer coverage that would otherwise be economically unviable or unavailable. The bill's passage removes the 2027 sunset uncertainty, allowing insurers to price multi-year policies with confidence. The increased certification threshold ($5M to $25M) reduces the number of events that trigger the federal program, shifting slightly more risk to insurers for smaller events, but the major benefit is the extended horizon. Market context (real data): As of April 30, 2026, insurer stock performance is mixed. AIG ($74.24) is down 1.2% in 7 days and 1.34% in 30 days, trading near its 52-week low of $71.25. CB ($327.44) is up 0.4% in 7 days and 0.46% in 30 days. ALL ($216.66) shows the strongest momentum: +1.78% in 7 days and +4.5% in 30 days, near its 52-week high of $219.48. TRV ($305.64) is up 0.96% in 7 days and 4.79% in 30 days. The divergence suggests investors are discriminating: ALL and TRV are outperforming, potentially due to stronger earnings or market share, while AIG's weakness may reflect company-specific headwinds rather than sector concerns. The TRIA extension — already telegraphed via the strong committee vote — is likely partially priced in. Timeline: The bill needs a House floor vote, then Senate passage (no companion bill has been introduced yet), then presidential signature. With the current 2027 sunset, there is legislative urgency, but the bill is early in the process. Strong bipartisan committee support (51-2) signals favorable odds.